Showing 971-980 of 1560 results for "".
- Researchers Offer New Insights into How Antibodies Function Against Herpes Simplex Virushttps://reachmd.com/news/researchers-offer-new-insights-into-how-antibodies-function-against-herpes-simplex-virus/2457155/Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101417 Findings from a
- Retinal Photoreceptors Use Dual Pathways to Tell Brain 'I've Seen the Light'https://reachmd.com/news/retinal-photoreceptors-use-dual-pathways-to-tell-brain-ive-seen-the-light/2456987/Credit: CC0 Public Domain Working with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that un
- New Omicron Subvariants Test Vaccine Limits, Reveal Unique Infection Challengeshttps://reachmd.com/news/new-omicron-subvariants-test-vaccine-limits-reveal-unique-infection-challenges/2456807/In a recent study published in the journal Cell, researchers investigated the infectivity, fusogenicity, and immune evasive potential of two novel Omicron s
- Innovative Strategies Against Immune Evasion in HNSCChttps://reachmd.com/news/innovative-strategies-against-immune-evasion-in-hnscc/2476078/The battle against cancer often feels like a never-ending struggle, especially as tumor cells develop cunning strategies to evade the immune system. In head and neck squamous cell carcinoma (HNSCC), immune evasion presents a significant challenge to treatment efficacy, demanding inn
- Novel Imaging Technique Shows Promise in Diagnosing Kidney Cancerhttps://reachmd.com/news/novel-imaging-technique-shows-promise-in-diagnosing-kidney-cancer/2468752/A groundbreaking study from the UCLA Health Jonsson Comprehensive Cancer Center has introduced a non-invasive imaging method that accurately detects clear-cell renal cell carcinoma (ccRCC), the most common and deadliest form of kidney cancer. Published in The Lancet Oncology, the finding
- New Protein Discovery Could Lead to Novel Osteoporosis Treatmentshttps://reachmd.com/news/new-protein-discovery-could-lead-to-novel-osteoporosis-treatments/2468426/Scientists at the University of Birmingham have identified a protein that plays a key role in preventing bone-forming cells from maturing, a discovery that could pave the way for new treatments for osteoporosis and other bone disorders. The protein, CLEC14A, is found on blood vessel cells known a
- Novel PET-CT Imaging Method Enhances Early Detection of Aggressive Kidney Cancerhttps://reachmd.com/news/new-imaging-technique-accurately-detects-aggressive-kidney-cancer/2468366/Researchers at UCLA have developed a cutting-edge, non-invasive imaging technique that could revolutionize the diagnosis of clear-cell renal cell carcinoma, the most common form of kidney cancer. By offering improved accuracy in detecting malignant tumors, the method promises to reduce unnecessar
- Research Spotlight: Identifying Potential New Protein Targets for Melanoma Therapeuticshttps://reachmd.com/news/research-spotlight-identifying-potential-new-protein-targets-for-melanoma-therapeutics/2467696/How would you summarize your study for a lay audience? Some proteins, such as programmed cell death protein 1 (PD1), can stop the immune system from attacking cancer cells and, therefore, support the growth of cancer. Th
- DART Releases New Clinical Guidelines for Nonmelanoma Skin Cancer Treatmenthttps://reachmd.com/news/dart-releases-new-clinical-guidelines-nonmelanoma-skin-cancer-treatment/2467534/The Dermatology Association of Radiation Therapy (DART) has published new clinical guidelines for the treatment of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) using image-guided superficial radiation therapy (IGSRT), according to a news release. The guidelines, developed
- ADI-270 Gains FDA Fast Track Status in Metastatic/Advanced ccRCChttps://reachmd.com/news/adi-270-gains-fda-fast-track-status-in-metastaticadvanced-ccrcc/2467343/A fast track designation has been given to ADI-270 from the FDA for treating metastatic or advanced clear cell renal cell carcinoma (ccRCC) previously treated with an immune checkpoint inhibitor and a VEGF inhibitor.ADI-270 is an allogeneic, off-th